FDA-Inspected Site

Octapharma Plasma, Inc.

3 FDA inspections are on record for Octapharma Plasma, Inc. in Dallas, United States.

483· Form 483 issued

Dallas, United States · Last updated July 10, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-03-22.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
18 Mar 2024 – 22 Mar 2024Biologics483View 483 →
29 Apr 2019 – 2 May 2019Biologics483View 483 →
18 Jul 2016 – 20 Jul 2016BiologicsClean

Observations on record

Form 483 observations cited at this site, most recent first.

22 Mar 2024
21 CFR 606.60(a)

Provide proper equipment to meet requirements

Cited by Ramon L Gonzalez-Prieto

2 May 2019
21 CFR 630.10(e)(2)

Additional Medical Assessment Factors

Cited by Everard A Irish

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 606.60(a)Cited across public-safe Form 483 observations1x
21 CFR 630.10(e)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Octapharma Plasma, Inc.'s 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat